Ovarian cancer trials in India

In India 7 Also abroad 795

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer
Where
Ansārinagar, Bhubaneswar, Hyderabad, Mumbai, Nagpur, Nashik, New Delhi, Pune, Thiruvananthapuram
Age
18 years and over
People
950 worldwide
Run by
AstraZeneca
See details and how to joinNCT07851025 · EU 2026-526895-22-00
Phase 3Taking people
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Where
Ahmedabad, Delhi, Kolkata, Mumbai, Nagpur, Nashik, Pune, Vadodara, Varanasi, Visakhapatnam
Age
18 years and over
People
582 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00
Phase 3Enrolling by invitation
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
Where
Bangalore, Bengaluru, Erode, Mysore, Nagpur, Pune, Surat, Varanasi
Age
18 years to 51 years
People
250 worldwide
Run by
Tolmar Inc.
See details and how to joinNCT05645536
Phase 3Taking people
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
Where
Ahmedabad, Bangalore, Gūrgaon, Kottayam, Madurai, Nashik, New Delhi, Vadodara
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07816666 · EU 2026-526776-23-00
Phase 3Taking people
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Where
Mumbai
People
1,780 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03067181
Phase 3Taking people
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Where
Bhubaneswar, Chennai, Delhi, Dhanvantari Nagar, Kolkata, Nagpur, Nashik, Surat, Tiruchirappalli
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00
No phaseTaking people
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Where
Mumbai
Age
18 years to 70 years
People
400
Run by
Tata Memorial Centre
See details and how to joinNCT02754115